Biotech, Pharmaceutical & Medical Equipment Auctions & Asset Sales

Ongoing modernization within biotech, pharmaceutical, and medical operations results in surplus laboratory, production, and facility assets as research priorities shift, products reach end of life, and manufacturing footprints evolve. Heritage Global Partners has a long track record supporting asset dispositions within this sector for research laboratories, clinical operations, and regulated manufacturing facilities, including surplus laboratory equipment sales and complete facility liquidations, frequently spanning multiple operational sites.

Heritage Global Partners maintains exclusive master service agreements with Pfizer and Amgen for the disposition of surplus biotech and pharmaceutical assets. Sales in this category originate from research and development transitions, facility consolidations, and corporate restructuring, supporting buyers active in regulated scientific and healthcare environments.

Typical Assets Sold

Current Auctions

Past Auctions

Online Auction Featuring Lab Equipment From An Innovative Drug Delivery Systems Company! Sandy Springs, GA.

Starting: Sep 16th, 2024 – 7:00am EDT

Ending: Sep 17th, 2024 – 11:00am EDT

Immediately Accepting Bids
Sale #5: Online Auction Featuring Surplus Nutraceutical and Confectionary Production Equipment From Catalent! South San Francisco, CA.

Starting: Oct 22nd, 2024 – 7:00am PDT

Ending: Oct 23rd, 2024 – 10:00am PDT

Immediately Accepting Bids
Online Auction Featuring Late Model Biotech and Pharmaceutical Lab Assets Surplus to Hookipa Pharma! Vienna, Austria.

Starting: Aug 15th, 2024 – 7:00am CEST

Ending: Aug 21st, 2024 – 11:00am CEST

Immediately Accepting Bids
Sale # 141: Featuring Cutting-Edge Biopharma R&D Lab Equipment from the World’s Premier Pharmaceutical Manufacturer! Multiple Locations.

Starting: Dec 18th, 2024 – 7:00am PST

Ending: Dec 19th, 2024 – 9:00am PST

Immediately Accepting Bids
Sale # 140: Featuring State-of-the-Art, Late Model Biopharma R&D Lab Equipment from Pfizer’s World Class Research Facility in Sandwich, UK!

Starting: Oct 29th, 2024 – 2:00am GMT

Ending: Oct 31st, 2024 – 1:00pm GMT

Immediately Accepting Bids
The 138th Sale Featuring State Of The Art Biopharma R&D Lab Equipment From The World’s Premier Pharmaceutical Manufacturer!

Starting: Oct 2nd, 2024 – 7:00am PDT

Ending: Oct 3rd, 2024 – 9:00am PDT

Immediately Accepting Bids
Sale #4: Online Auction Featuring Surplus Oral Solid Dose Equipment From Catalent! Winchester, KY.

Starting: Oct 15th, 2024 – 7:00am EDT

Ending: Oct 16th, 2024 – 11:00am EDT

Immediately Accepting Bids
State-of-the-Art Biopharma Equipment from MabPlex USA: Late-Model Bioreactors, Chromatography Skids & More! San Diego, CA.

Starting: Jan 20th, 2025 – 7:00am PST

Ending: Jan 21st, 2025 – 9:00am PST

Immediately Accepting Bids
Sale #2: Surplus Processing & Packaging Equipment from PL Developments: Fillers, Cappers, Cartoners, Labelers & More! Multiple Locations, US.

Starting: Dec 11th, 2024 – 7:00am EST

Ending: Dec 12th, 2024 – 12:00pm EST

Immediately Accepting Bids
Online Auction Featuring Late Model Lab Equipment From A Contract Developer and Manufacturer! Austin, TX.

Starting: Jul 23rd, 2024 – 11:00am CDT

Ending: Jul 25th, 2024 – 9:00am CDT

Immediately Accepting Bids

Managing surplus lab or regulated manufacturing assets?

Buyer FAQs

Many cleanroom components, HVAC systems, and lab assets can be reused in non-GMP or pilot-scale applications with modification.
Buyers should evaluate service history, manufacturer support status, software compatibility, and calibration requirements.
Validation documentation may be available when provided by the seller and is disclosed within the listing of assets for sale.

Seller FAQs

Sales are often structured to align with internal QA, EHS, and compliance teams prior to equipment release.
Yes. Asset-only dispositions can be structured without referencing product names or research outcomes.

Sales are often driven by pipeline changes, site consolidations, regulatory strategy shifts, or the retirement of specific research or production programs.